Glenmark's Win: NPPA revises price of Telmisartan, Cilnidipine FDC after data review
New Delhi: Drug maker, Glenmark Pharmaceuticals' appeal against the earlier price fixation for its cardiovascular drug combination, Cilnidipine 20 mg and Telmisartan 40 mg, has seen daylight as the...
